SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950137-09-003196
Filing Date
2009-04-23
Accepted
2009-04-23 17:26:33
Documents
2
Group Members
CRANSHIRE CAPITAL, L.P.DOWNSVIEW CAPITAL, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D c50799sc13d.htm SC 13D 126657
2 EX-99.1 c50799exv99w1.htm EX-99.1 6984
  Complete submission text file 0000950137-09-003196.txt   135565
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-48459 | Film No.: 09767428
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3100 DUNDEE ROAD SUITE 703 NORTHBROOK IL 60062
Business Address 3100 DUNDEE ROAD SUITE 703 NORTHBROOK IL 60062 847 562-9030
KOPIN MITCHELL P (Filed by) CIK: 0001116628 (see all company filings)

IRS No.: 000000000
Type: SC 13D